cytarabine has been researched along with Muscular Weakness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakare, BY; Bello, FO; Ojo, OT; Olatunji, AO; Olatunji, PO | 1 |
| Aiello-Laws, L; Rutledge, DN | 1 |
| Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S | 1 |
| Conter, V; Dell'Orto, M; Ferrari, E; Jankovic, M; Malberti, R; Milani, M; Rizzari, C | 1 |
1 review(s) available for cytarabine and Muscular Weakness
| Article | Year |
|---|---|
Management of adult patients receiving intraventricular chemotherapy for the treatment of leptomeningeal metastasis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Blepharoptosis; Brain Neoplasms; Carcinoma; Cytarabine; Drug Compounding; Drug Monitoring; Evidence-Based Medicine; Fatal Outcome; Humans; Injections, Intraventricular; Low Back Pain; Lymphoma, AIDS-Related; Male; Meningeal Neoplasms; Muscle Weakness; Nurse's Role; Nursing Assessment; Oncology Nursing; Practice Guidelines as Topic | 2008 |
3 other study(ies) available for cytarabine and Muscular Weakness
| Article | Year |
|---|---|
A case of acute megakaryoblastic leukaemia (FAB M7), a rare type of acute myeloid leukemia (AML), in a teenager.
Topics: Anemia; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Blood Transfusion; Cytarabine; Daunorubicin; Fatigue; Female; Humans; Immunophenotyping; Leukemia, Megakaryoblastic, Acute; Lost to Follow-Up; Muscle Weakness; Thrombocytopenia; Young Adult | 2018 |
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 2008 |
Transient myeloproliferative disorder associated with trisomy 21: is a short course of chemotherapy indicated in patients with liver impairment and severe clinical problems?
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Drug Administration Schedule; Dyspnea; Fever; Hepatomegaly; Humans; Infant, Newborn; Male; Muscle Weakness; Myeloproliferative Disorders; Nutrition Disorders; Splenomegaly | 1999 |